0.00Open2.50Pre Close0 Volume4 Open Interest17.50Strike Price0.00Turnover189.31%IV17.26%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier16DDays to Expiry2.50Extrinsic Value100Contract SizeAmericanOptions Type-0.3882Delta0.0535Gamma7.25Leverage Ratio-0.0861Theta-0.0039Rho-2.81Eff Leverage0.0145Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet